| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other expenses, net | -1,001 | -1,476 | -1,170 | -1,379 |
| Income (loss) before provision for income taxes | 1,049 | 1,713 | -3,284 | -9,941 |
| Income tax benefit (expense) | 270 | 181 | -1,085 | -817 |
| Net income (loss) | 779 | 1,532 | -2,199 | -9,124 |
| Income (loss) per share basic (in dollars per share) | 0.04 | 0.08 | -0.12 | -0.5 |
| Income (loss) per share diluted (in dollars per share) | 0.04 | 0.08 | -0.12 | -0.5 |
| Weighted average number of shares outstanding basic (in shares) | 18,576,199 | 18,510,834 | 18,470,808 | 18,323,542 |
| Weighted average number of shares outstanding diluted (in shares) | 19,459,877 | 19,015,496 | 18,470,808 | 18,323,542 |
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)